Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.135 USD | +2.50% | -1.53% | +22.04% |
11:15am | Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US | MT |
05-27 | Global markets live: UBS, Tesla, Nvidia, Apple, Micron... |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.04% | 292M | |
+10.47% | 114B | |
+11.33% | 105B | |
-3.96% | 23.83B | |
-0.67% | 21.73B | |
-10.12% | 18.1B | |
-42.36% | 16.34B | |
-16.48% | 16.13B | |
+1.65% | 13.75B | |
+32.36% | 11.76B |
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- Transcript : Vanda Pharmaceuticals Inc., Q1 2024 Earnings Call, May 08, 2024